Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SMTIthis companySanara MedTech Inc.	$31.71	-5.36×	33.96×	1.95×	6.67×	266.6%	90.1%	8.9%	-36.4%	-633.5%	16.7%	1.1%	8.13×	0.91×	1.35×	1.8×	0.0%	5	3.63	1	C-
LFMDLifeMD, Inc.	$2.04	-14.83×	6.65×	0.79×	-81.36×	-847.8%	79.8%	-4.0%	-3.7%	-30.7%	-26.0%	-0.8%	0.27×	20.08×	-5.64×	1.25×	2.0%	4	-2.25	1	D+
NEONeoGenomics, Inc.	$17.33	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
SGHTSight Sciences, Inc.	$10.53	-10.72×	6.47×	5.35×	-11.05×	-82.2%	86.2%	-48.0%	-49.7%	-60.1%	-35.4%	-7.2%	0.64×	1.56×	-7.21×	10.22×	0.0%	4	1.35	1	C-
STXSStereotaxis, Inc.	$1.12	-9.2×	11.17×	6.46×	-10.02×	-355.9%	52.7%	-68.3%	-66.8%	-115.6%	-72.4%	-6.6%	0.29×	0.4×	0×	1.51×	0.0%	3	-14.05	1	D+
TRDAEntrada Therapeutics, Inc.	$4.64	-2.96×	1.39×	16.73×	-2.78×	84.8%	83.9%	-613.7%	-565.5%	-47.0%	-43.7%	-30.5%	0.17×	0.28×	0×	12.53×	0.0%	1	-0.8	2	B-
Peer median	—	-10.72×	6.47×	5.35×	-11.05×	-168.7%	79.8%	-48.0%	-49.7%	-47.0%	-35.4%	-6.6%	0.29×	0.4×	-5.64×	4.26×	0.0%	4	-0.8	1	—